Advanced Ovarian Cancer: A Prospective Randomised Trial of Chlorambucil Versus Combined Cyclophosphamide and Cis-diamminedichloroplatinum

David Bell, Robert L. Woods, John A. Levi, R. M. Fox, Martin H.N. Tattersall

Australian and New Zealand Journal of Medicine · 1982 · 36 citations · 7 references

Concepts

Abstract

Abstract: Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum. D. R. Bell, R. L. Woods, J. A. Levi, R. M. Fox and M. H. N. Tattersall, Aust. N.Z. J. Med., 1982,12, pp. 245–249. Thirty-seven patients with advanced ovarian cancer were treated in a prospective, randomised trial comparing chlorambucil with a combination of cyclophosphamide and cis-diamminedichloroplatinum (cis DDP). Treatment with the combination was associated with an increased overall response rate (69% versus 23%) (p = 004). A response was associated with a longer median survival but no survival advantage was demonstrated for patients who received cyclophosphamide/cis DDP. A larger study is needed to evaluate fully the potential of regimens containing cis DDP in the management of advanced ovarian cancer.

References

7